What is Pro-Dex, Inc. (PDEX) stock price today?

Pro-Dex, Inc. (PDEX) is currently trading at $62.49, up 0.45% today.

What is PDEX P/E ratio?

Pro-Dex, Inc.'s P/E ratio is 15.49. This is near the market average.

What is PDEX return on equity (ROE)?

Pro-Dex, Inc.'s return on equity (ROE) is 31.05%, indicating how efficiently the company generates profit from shareholders' equity. This is considered high quality.

What is Pro-Dex, Inc.'s market cap?

Pro-Dex, Inc. has a market capitalization of $199.52M.

NASDAQ · Medical - Instruments & Supplies

Pro-Dex, Inc. (PDEX) Stock

$62.49 +0.45% NASDAQ: PDEX Healthcare

Valuation

Metric	Value
Price	$62.49
Market Cap	$199.52M
P/E Ratio	15.49
P/B Ratio	4.43
P/S Ratio	2.69
EPS (TTM)	$3.63
52-Week High	$77.00
52-Week Low	$23.47
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	31.05%
ROA	18.34%
ROCE	21.11%
Gross Margin	27.78%
Operating Margin	14.48%
Net Margin	17.62%
Debt/Equity	0.38
Current Ratio	3.13

Annual Financials (USD)

Metric	2022	2023	2024	2025	2026
Revenue	$42.0M	$46.0M	$54.0M	$67.0M	$78.0M
Operating Profit	$5.0M	$6.0M	$7.0M	$11.0M	$13.0M
Net Profit	$5.0M	$7.0M	$2.0M	$9.0M	$14.0M
EPS	$1.21	$1.95	$0.60	$2.67	$4.12
Op Margin	12.2%	12.5%	13.3%	16.1%	16.8%

Balance Sheet (USD)

Metric	2022	2023	2024	2025	2026
Total Assets	$49.0M	$52.0M	$52.0M	$61.0M	$75.0M
Total Liabilities	$24.0M	$20.0M	$22.0M	$25.0M	$27.0M
Cash	$1.0M	$3.0M	$3.0M	$0	$8.0M
Borrowings	$16.0M	$15.0M	$14.0M	$17.0M	$18.0M

Latest News

Pro-Dex, Inc. Announces Fiscal 2026 Third Quarter and Nine Month Results ACCESS Newswire · Apr 30, 2026

Cash Flow (USD)

Metric	2022	2023	2024	2025	2026
Operating Cash Flow	$-1.0M	$5.0M	$6.0M	$-2.0M	$7.0M
Investing Cash Flow	$-3.0M	$-2.0M	$-3.0M	$-1.0M	$3.0M
Financing Cash Flow	$-2.0M	$-2.0M	$-3.0M	$-4.0M	$-3.0M
Net Cash Flow	$-3.0M	$2.0M	$0	$-2.0M	$8.0M
Free Cash Flow	$-3.0M	$4.0M	$5.0M	$-3.0M	$7.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	0.29
EV / EBITDA	10.96
FCF Yield	3.30%
Quick Ratio	2.45
Interest Coverage	16.00
Return 1Y	26.02%
Return 3Y	215.43%
Return 5Y	102.15%

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
APYXApyx Medical Corporation	$2.59	+9.75%	-12.68	$109.07M	0.00%
CGTXCognition Therapeutics, Inc.	$0.88	-2.04%	-4.82	$78.48M	0.00%
GLSIGreenwich LifeSciences, Inc.	$16.53	+9.18%	-11.03	$242.63M	0.00%
IXHLIncannex Healthcare Inc.	$3.10	-3.12%	-2.87	$37.09M	0.00%
LUCDLucid Diagnostics Inc.	$0.64	-1.86%	-1.35	$121.71M	0.00%

About Pro-Dex, Inc.

Pro-Dex, Inc. is led by CEO Richard Lee Van Kirk Jr., publicly traded since 1986.

Pro-Dex, Inc. (PDEX) stock trades at $62.49 with a market capitalization of $199.52M. The stock is valued at a price-to-earnings (P/E) ratio of 15.49, price-to-book of 4.43, price-to-sales of 2.69. Over the past 52 weeks the stock has ranged between $23.47 and $77.00, and currently trades 18.8% below its 52-week high.

On profitability, Pro-Dex, Inc. generates a return on equity (ROE) of 31.05% — well above the market average, a sign of a high-quality business, return on capital employed of 21.11%, an operating margin of 14.48%, a net profit margin of 17.62%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Screens featuring this stock

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks Nasdaq High ROE Stocks All stock screens

Run Stock Screener Investing Guides